T. Rowe Price Associates
KND

T. Rowe Price Associates’s Kindred Healthcare KND Stock Holding History

T. Rowe Price Associates’s Portfolio KND Stock Details KND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-29,023
Closed -$197K – 2651
2017
Q3 		$197K Hold
29,023
– – ﹤0.01% 2416
2017
Q2 		$338K Hold
29,023
– – ﹤0.01% 2199
2017
Q1 		$242K Buy
29,023
+34
+0.1% +$266 ﹤0.01% 2334
2016
Q4 		$228K Hold
28,989
– – ﹤0.01% 2345
2016
Q3 		$296K Hold
28,989
– – ﹤0.01% 2220
2016
Q2 		$327K Sell
28,989
-7,787
-21% -$97.5K ﹤0.01% 2128
2016
Q1 		$454K Buy
36,776
+17,800
+94% +$185K ﹤0.01% 2017
2015
Q4 		$226K Sell
18,976
-6,177
-25% -$79.9K ﹤0.01% 2264
2015
Q3 		$396K Hold
25,153
– – ﹤0.01% 2046
2015
Q2 		$510K Hold
25,153
– – ﹤0.01% 1992
2015
Q1 		$598K Buy
25,153
+5,273
+27% +$107K ﹤0.01% 1908
2014
Q4 		$361K Sell
19,880
-1,519,400
-99% -$30.1M ﹤0.01% 2098
2014
Q3 		$29.9M Sell
1,539,280
-488,400
-24% -$10.6M 0.01% 1005
2014
Q2 		$46.8M Sell
2,027,680
-794,400
-28% -$19.4M 0.01% 887
2014
Q1 		$66.1M Sell
2,822,080
-693,200
-20% -$14.3M 0.01% 766
2013
Q4 		$69.4M Sell
3,515,280
-175,530
-5% -$2.83M 0.02% 721
2013
Q3 		$49.6M Buy
3,690,810
+54,700
+2% +$787K 0.01% 818
2013
Q2 		$47.7M Buy
+3,636,110
New +$43.5M 0.01% 801

Other funds holding KND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates's KND Position: Q4 2017 in Review

T. Rowe Price Associates sold out of Kindred Healthcare (KND) in Q4 2017, closing a stake of 29,023 shares — an estimated $197K sold.

T. Rowe Price Associates first reported a position in KND in Q2 2013 and held it in 18 quarters. The position peaked at $69.4M in Q4 2013. 181 funds tracked by Wall St. Rank hold KND as of Q4 2017.

  • T. Rowe Price Associates reported no remaining Kindred Healthcare position as of Q4 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 29,023 Kindred Healthcare shares in Q4 2017, an estimated $197K.
  • T. Rowe Price Associates first reported a position in Kindred Healthcare in Q2 2013 and held it in 18 quarters.
  • T. Rowe Price Associates's Kindred Healthcare position peaked at $69.4M in Q4 2013.
  • 181 funds tracked by Wall St. Rank held Kindred Healthcare as of Q4 2017.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.